Do More With Reuters
Partner Services

Quote For Valeant Pharmaceuticals International

Valeant Pharmaceuticals International (VRX.N) (New York Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  25 Nov 2009
33.11USD
Price Change
+0.26
Percent Change
+0.79%
 
Research a stock:   symbol lookup
$33.11
25 Nov 2009
+0.79%
$33.11
--
395,278
$33.26
$32.82
$34.44
$15.64
0.55
760,712

 

News

Key Developments

Officers

Name Current Position Compensation
Pearson, J. Michael Chairman of the Board, Chief Executive Officer 9,767,394
Chaudhuri, Bhaskar President --
Blott, Peter Chief Financial Officer, Executive Vice President 1,137,057

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) $2,693.06
Shares Outstanding (Mil.) 81.34
Float (Mil.) 67.80
Dividend Information
Yield % -99,999.99
Annual Dividend ($ USD) 0.00
Payout Ratio(TTM) % --
Financial Strength
Quick Ratio 1.36
Current Ratio 1.58
LT Debt/Equity 163.68
Total Debt/Equity 177.96
Valuation Ratios
Price/Earnings(TTM) --
Price/Sales(TTM) 3.48
Price/Book(TTM) 7.98
Price/Cash Flow(TTM) 76.56
Per Share Data
Earnings(TTM) $-0.48
Sales(TTM) $9.21
Book Value(MRQ) $4.15
Cash Flow(TTM) $0.42
Cash(MRQ) $4.76
Management Effectiveness
Return on Equity(TTM) -10.33
Return on Assets(TTM) -3.20
Return on Investment(TTM) -4.21
Margins
Gross Margin(TTM) % 75.41
Operating Margin(TTM) % 2.52
Profit Margin(TTM) % -5.59

Commodities

Commodity Last Pct Chg Trade Date/Time
Oil 74.3 -3.62% 11/27 14:00 IST
Gold 1147.2 -3.47% 11/27 13:41 IST